Health Condition 1: R69- Illness, unspecified
Conditions
Interventions
Intervention1: GROUP A: PATEINT RECEIVING NEBULIZED DEXMEDITOMEDINE 0.75-2 MICROGRAMS/KG 30 minutes before Intubation
Control Intervention1: GROUP B: PATEINTS RECEIVING NEBULIZED NEBULIZED MIDAZOLAM 0
Sponsors
DR Tejaswini K M
Eligibility
Inclusion criteria
Inclusion criteria: Age:5-12 years American Society of Anesthesiologists Class I AND II Elective Surgery under General Anesthesia Mallampati Class I AND II
Exclusion criteria
Exclusion criteria: Refusal to participate in the study Mallampati Class III and IV Patient with Critical Illnesses Patient who is known case of Seizures and Congenital Abnormalities Allergy to Midazolam and Dexmedetomidine American Society of Anesthesiologists 3 and 4, Obesity grade 3 and 4 Respiratory Tract Infections Developmental Delay and Psychiatric Illnesses Emergency surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO STUDY THE EFFICACY OF NEBULIZED DEXMEDITOMEDINE AND NEBULIZED MIDAZOLAM AS SEDATIVE PREDICATION FOR FACILITATING FACE MASK ACCEPTANCETimepoint: 0, 5 minute, 10 minute, 20 minute, 30 minutes and at the end of the surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the effect of nebulized dexmedetomidine, midazolam as sedative premedication for facilitating face mask acceptance. To compare the hemodynamic stability during laryngoscopy. To study the other effects of the drugs on the hemodynamics and the homeostasis apart from the sedative, anti-anxiety and analgesic properties To assess the onset and duration of sedation. To compare any adverse effects associated with each drug. To compare the quality of the depth of analgesia and sedation given by nebulized midazolam and dexmedetomidine Timepoint: 0, 5 minute, 10 minute, 20 minute, 30 minutes and at the end of the surgery | — |
Countries
India
Contacts
Public ContactDR Srinivas V Y
Mysore Medical College and Research Institute
Outcome results
None listed